VR Logo

Syngene International Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Get the Stocks!

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Scientific research and development

Incorporated: 1993

Chairman: Kiran Mazumdar Shaw

Managing Director: Jonathan Hunt

Group: --

Listing: NSE: SYNGENE, BSE: 539268

Headquarters: Bengaluru, Karnataka

Website: www.syngeneintl.com

Key Facts

Market cap: R 19,668.00 Cr

Revenue (TTM): R 2,012.60 Cr

Earnings (TTM): R 398.10 Cr

Cash: R 1,019.90 Cr

Total Debt: R 685.60 Cr

Promoters' ownership: 70.65%

Liquidity: High

52 Week range: R 212.55 - 504.20

Face value: R10.00

Shares outstanding: 40,00,00,000

10 Years Aggregate:

  • CFO: 3,098.70 Cr
  • EBITDA: 3,197.30 Cr
  • Net Profit: 2,084.70 Cr

Stock Performance

Time Period Syngene International S&P BSE Healthcare S&P BSE Mid Cap
YTD50.4946.26-3.66
1 month9.4818.537.64
3 months52.6928.6226.23
1 Year52.9454.375.46
3 Years29.8815.39-0.76
5 Years--2.334.52
10 Years--13.466.63
As on 10-Aug-2020
Year Syngene International S&P BSE Mid Cap S&P BSE Healthcare
201914.86-3.05-3.55
20183.46-13.31-5.89
2017-3.6548.130.49
201634.517.97-12.88

Review & Analysis